Archives

  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • DMG-PEG2000-NH2: Biocompatible PEGylation Linker for LNP ...

    2026-01-22

    DMG-PEG2000-NH2: Biocompatible PEGylation Linker for LNP Drug Delivery

    Executive Summary: DMG-PEG2000-NH2 is a polyethylene glycol (PEG) derivative functionalized with a primary amine, facilitating amide bond formation with carboxyl-containing biomolecules (APExBIO). This reagent enables the construction of lipid-based drug delivery systems such as liposomes and lipid nanoparticles, which are central to encapsulating therapeutic agents like siRNA (contrast: details LNP optimization). DMG-PEG2000-NH2 exhibits high water, ethanol, and DMSO solubility, and is supplied at >90% purity. Its use improves conjugate biocompatibility, solubility, and stability, supporting advanced pharmaceutical and biochemical workflows (extends: workflow troubleshooting). The reagent must be stored at -20°C to maintain integrity, with short-term solutions recommended for best performance.

    Biological Rationale

    Polyethylene glycol (PEG) derivatives are widely used to enhance the pharmacokinetic profile of therapeutic agents through PEGylation. The addition of PEG chains increases solubility, reduces immunogenicity, and prolongs circulation times for biomolecule conjugates (Chen et al., 2021). Functionalizing PEG with an amine group, as in DMG-PEG2000-NH2, enables selective covalent attachment to carboxyl groups via amide bond formation. This chemical strategy is essential for the stable conjugation of proteins, peptides, and small molecules in drug delivery applications (updates: mechanistic context). Lipid nanoparticles (LNPs) and liposomes, key vectors for nucleic acid and small-molecule therapeutics, benefit from PEGylation as it confers enhanced stability and reduced non-specific uptake.

    Mechanism of Action of DMG-PEG2000-NH2

    DMG-PEG2000-NH2 acts as a bifunctional linker. Its primary amine (-NH2) reacts with activated carboxyl groups, typically via carbodiimide (EDC/NHS) chemistry, forming stable amide bonds. The DMG (dimyristoyl glycerol) moiety enables lipid insertion into bilayers, anchoring the PEG chain on the nanoparticle surface. The PEG2000 backbone (molecular weight: 2528 Da) creates a hydrophilic corona, enhancing colloidal stability and circulation time by reducing protein adsorption and immune clearance (APExBIO). The net result is a platform for site-specific, biocompatible conjugation of therapeutic and diagnostic molecules.

    Evidence & Benchmarks

    • DMG-PEG2000-NH2 enables amide bond formation with carboxyl-containing biomolecules under standard EDC/NHS activation conditions at pH 6–7.4 (room temperature, aqueous buffer) (Chen et al., 2021).
    • The product is soluble at ≥25.3 mg/mL in water, ≥52 mg/mL in ethanol, and ≥51.6 mg/mL in DMSO, supporting a range of formulation conditions (APExBIO).
    • PEGylation of lipid nanoparticles with PEG2000 derivatives reduces immunogenicity and prolongs blood circulation half-life in vivo (Interlink: LNP delivery optimization).
    • DMG-PEG2000-NH2 exhibits purity >90% and is batch-verified with Certificate of Analysis (COA) and MSDS available (APExBIO).
    • LNPs formulated with DMG-PEG2000-NH2 demonstrate enhanced encapsulation efficiency for siRNA and other nucleic acids compared to non-PEGylated controls (Interlink: Conjugation efficiency case study).

    Applications, Limits & Misconceptions

    DMG-PEG2000-NH2 is primarily used in the following contexts:

    • Lipid nanoparticle (LNP) and liposome formulation: The molecule acts as a surface stabilizer and linker for the attachment of targeting ligands or drugs.
    • Bioconjugation reagent: Used for covalent attachment of proteins, peptides, and other carboxyl-bearing biomolecules via amide bonds.
    • PEGylation for enhanced solubility and stability: Increases aqueous solubility and improves in vivo stability of conjugates.

    Common Pitfalls or Misconceptions

    • DMG-PEG2000-NH2 does not react with non-carboxyl functional groups unless appropriately activated; it is not a universal crosslinker.
    • Prolonged storage of DMG-PEG2000-NH2 solutions may lead to hydrolysis or degradation; only freshly prepared solutions should be used for critical reactions (APExBIO).
    • The reagent does not inherently confer cell targeting; specific targeting must be engineered by further conjugation.
    • Application outside the recommended pH range (6–7.4) may reduce amide bond formation efficiency.
    • PEGylation may reduce cell uptake for some formulations due to steric hindrance; optimization is application-specific.

    Workflow Integration & Parameters

    DMG-PEG2000-NH2 (SKU M2006) is supplied as a powder at >90% purity. It is reconstituted in DMSO, ethanol, or water to the desired working concentration (e.g., 10–50 mg/mL) immediately prior to use. Amide coupling is typically performed by mixing the NH2-PEG derivative with an activated carboxyl partner (e.g., NHS ester or EDC-activated acid) in an aqueous buffer (pH 6–7.4) at room temperature for 1–2 hours. Excess reagent is removed by dialysis or chromatography. For LNP or liposome assembly, DMG-PEG2000-NH2 can be included during the lipid hydration step or post-insertion after nanoparticle formation. Storage at -20°C is required for both powder and short-term solutions. Detailed protocols are available in the product documentation and manufacturer’s website (see DMG-PEG2000-NH2 product page).

    This article expands upon prior workflow-focused content, such as "DMG-PEG2000-NH2: Optimizing Bioconjugation and LNP Drug D...", by providing structured evidence and explicit mechanistic boundaries for practitioners.

    Conclusion & Outlook

    DMG-PEG2000-NH2 from APExBIO is a well-characterized, high-purity NH2-PEG derivative for constructing biocompatible lipid nanoparticles and liposomes. Its primary amine functionality supports robust amide bond formation, enabling precise bioconjugation strategies for proteins, peptides, and nucleic acids. The reagent’s defined solubility, purity, and storage conditions ensure reproducibility in both research and translational settings. Ongoing advances in PEG-lipid chemistry will further broaden its utility for next-generation drug delivery, diagnostic, and therapeutic applications. For detailed protocols and product specifications, refer to the DMG-PEG2000-NH2 product page.